imatinib mesylate has been researched along with Anterior Choroidal Artery Infarction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Gazeau, F; Chalayer, E; De Broucker, T; Denier, C; Groh, M; Guidoux, C; Hamidou, M; Hunault, M; Kahn, JE; Lefèvre, G; Lyoubi, A; Meunier, R; Muron, T; Rohmer, J; Sène, D; Slama, B; Tennenbaum, J; Venditti, L | 1 |
| Lee, SR; Yhim, HY | 1 |
| Choi, CU; Kim, EJ; Lee, S; Na, JO | 1 |
| D'Orazio, J; Pulliam, J | 1 |
4 other study(ies) available for imatinib mesylate and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction.
Topics: Adult; Brain; Cerebral Infarction; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Ischemic Stroke; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Receptor, Platelet-Derived Growth Factor alpha; Recurrence; Retrospective Studies; Treatment Outcome | 2021 |
Rapid left ventricular thickening and thrombus caused by FIP1L1/PDGFRA-negative hypereosinophilic syndrome.
Topics: Benzamides; Biopsy; Cerebral Infarction; Disease Progression; Echocardiography; Fibrosis; Genetic Predisposition to Disease; Hemodynamics; Humans; Hypereosinophilic Syndrome; Hypertrophy, Left Ventricular; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Phenotype; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Thrombosis; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Regression of biventricular Loeffler's endocarditis after early treatment.
Topics: Adult; Aphasia; Cerebral Infarction; Early Diagnosis; Echocardiography; Follow-Up Studies; Headache; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Risk Assessment; Secondary Prevention; Treatment Outcome; Warfarin | 2017 |
Hypereosinophilic syndrome presenting as acute myocardial infarction in an adolescent.
Topics: Adolescent; Benzamides; Cerebral Infarction; Drug Therapy, Combination; Electrocardiography; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Myocardial Infarction; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2011 |